| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |